Literature DB >> 1083396

Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.

F V Chisari, J A Routenberg, T S Edgington.   

Abstract

The expression of selected lymphocyte surface-membrane markers was evaluated in 37 patients with acute viral hepatitis B, 10 of whom were studied serially through the resolving and convalescent phases of disease. Bone marrow-derived (B) lymphocytes were identified by reference to surface immunoglobulin, whereas normal thymus-derived (T) lymphocytes were assayed by their capacity to form spontaneous nonimmune rosettes with sheep erythrocytes (E rosettes, ER). During the acute and resolving phases of viral hepatitis B, the relative and absolute number of ER-positive lymphocytes was significantly reduced, whereas the number of surface immunoglobulin-positive lymphocytes and the absolute lymphocyte count remained normal. This resulted in the appearance of a third population of cells, deficient in respect to both surface immunoglobulin and ER markers. Such cells accounted for nearly 25% of peripheral blood lymphocytes, approximately 5 x 105ml blood. Depression of the number of ER-positive lymphocytes occurred at least once during the course of disease in every patient studied serially, and was observed in 55 of 67 individual assays of the 37 cases of acute viral hepatitis B. Lymphocytes from some patients reacquired ER function when cultured in fetal calf serum but not in the presence of autologous serum. Such autologous serum was capable of suppressing ER function of lymphocytes from normal donors. The extrinsic suppression of er function by a serum factor (designated as the Rosette Inhibitory Factor), was found to be time dependent, characterized by a 4-h latent period and requiring approximately 18 h for maximum attenuation of ER function. The Serum Rosette Inhibitory Factor was: (a) heat and freeze-thaw stable, (b) nondialyzable, (c) physically separable from hepatitis B surface antigen, (d) not a lymphocytotoxic antibody, and (e) had the buoyant density of a lipoprotein. This extrinsic mechanism was observed in 41.8% of patients with reduced numbers of ER-positive lymphocytes. The Rosette Inhibitory Factor was not detectable in the serum of the remaining 58.2% of the cases of acute and resolving viral hepatitis B despite the presence of reduced numbers of ER-positive lymphocytes. The lymphocytes from these cases did not reacquire ER function when cultured in the absence of autologous serum. The mechanisms responsible for the suppression of normal ER function in these cases appears to be intrinsic to the lymphocytes and not the result of a humoral factor. The T lymphocyte lineage of cells deficient in respect to ER function, whether of intrinsic or extrinsic type, was demonstrated by their capacity to form spontaneous rosettes with neuraminidase-treated sheep erythrocytes. Both intrinsic and extrinsic suppression of T lymphocyte ER function commonly occurred during the first 4 wk of acute viral hepatitis B.9 of the 10 patients followed serially continued to manifest defective ER function at 12 wk...

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083396      PMCID: PMC436776          DOI: 10.1172/JCI108391

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Human T lymphocyte receptors for sheep erythrocytes: conditions for binding including inhibition by cytochalasin B.

Authors:  J H Kersey; D J Hom; P Buttrick
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

2.  Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction.

Authors:  Z Bentwich; S D Douglas; F P Siegal; H G Kunkel
Journal:  Clin Immunol Immunopathol       Date:  1973-07

3.  Peripheral blood T and B cells in chronic inflammatory bowel disease.

Authors:  R G Strickland; S Korsmeyer; R D Soltis; I D Wilson; R C Williams
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

4.  Rosette-forming cells, immunologic deficiency diseases and transfer factor.

Authors:  J Wybran; A S Levin; L E Spitler; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

5.  The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

6.  Effects of non-viable measles virus on proliferating human lymphocytes. 2. Characteristics of the suppressive reaction.

Authors:  B Zweiman; M F Miller
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

7.  Immunochemistry of the hepatitis B virus: 125I HB Ag ligand.

Authors:  F V Chisari; J L Gerin; T S Edgington
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

8.  The role of complement in the HL-A antibody-mediated lysis of lymphocytes.

Authors:  S Ferrone; N R Cooper; M A Pellegrino; R A Reisfeld
Journal:  Transplant Proc       Date:  1974-03       Impact factor: 1.066

9.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein.

Authors:  F V Chisari; T S Edgington
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  19 in total

1.  Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

2.  Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors.

Authors:  B Maisch; P Schuff-Werner; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

4.  Interleukin-1 production in acute viral hepatitis.

Authors:  C Müller; I Gödl; R Ahmad; H M Wolf; J W Mannhalter; M M Eibl
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

5.  The effect of levamisole on E-rosette formation by trypsinized lymphocytes.

Authors:  R Lomnitzer; A R Rabson
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

6.  Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.

Authors:  F V Chisari; L K Curtiss; F C Jensen
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

7.  An immunosuppressive lipoprotein fraction from TEPC-183 bearing mice.

Authors:  L Wolfe; H F Havas; M R Fenton
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

8.  Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).

Authors:  L S Si; T L Whiteside; R R Schade; D H Van Thiel
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

9.  Investigation of T gamma cells and T mu cells in peripheral blood of children with different types of viral hepatitis.

Authors:  X R Zhang; J Y Kong
Journal:  Acta Acad Med Wuhan       Date:  1983

10.  [Follow-up study on antibody dependent cell-mediated cytotoxicity and cell-mediated cytotoxicity to HBs-antigen conjugated target cells in patients with hepatitis B (author's transl)].

Authors:  H Warnatz; W Gerlich; W Gutmann; R Werntges
Journal:  Klin Wochenschr       Date:  1980-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.